The SA Journal Diabetes & Vascular Disease Volume 16 No 2 (November 2019)

1 / 40

Featured in this issue:
Volume 16 Number 2
A Lupin Group Company
CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
the endurance ACE-inhibitor
PEARINDA 4, 8. Each tablet contains 4, 8 mg perindopril tert-butylamine respectively. S3 A41/7.1.3/0649, 0650. NAM NS2 10/7.1.3/0476, 0477. For
full prescribing information, refer to the professional information approved by SAHPRA, April 2009. PEARINDA PLUS 4. Each tablet contains 4 mg
perindopril tert-butylamine and 1,25 mg indapamide. S3 A41/7.1.3/0633. NAM NS2 10/7.1.3/0611. For full prescribing information, refer to the
professional information approved by SAHPRA, April 2010. 1) The EUROPA study Investigators. “Efficacy of perindopril in reduction of cardiovascular
events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study)”. The
Lancet 2003;362:782-788. 2) The PREAMI study Investigators. “Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular
remodelling and clinical outcome. Results of the randomized perindopril and remodelling in elderly with acute myocardial infarction (PREAMI) study”. Arch
Intern Med 2006;166:659-666. 3) PROGRESS Collaborative Group. “Randomised trial of a perindopril-based blood-pressure-lowering regimen among
6105 individuals with previous stroke or transient ischaemic attack”. The Lancet 2001;358:1033-41. 4) Guerin AP, et al. “Impact of Aortic Stiffness
Attenuation on Survival of Patients in End-Stage Renal Failure”. Circulation2001;103;987-992. PAI594/04/2019.
Perindopril has proven outcomes in:
• Coronary Artery Disease1
• Acute Myocardial Infarction2
• Stroke3
• End-stage Renal Failure4
Need endurance
when treating CVS disease?
November 2019
SAJDVD
The South African Journal of DIABETES & VASCULAR DISEASE
The electronic version of
the journal is available at
• High risk of falls in
young to middle-aged
adults with diabetes
• Microvascular
complications in
diabetics with and
without hypothyroidism
• Elevated levels of
carboxymethyl-
lysine and endothelial
dysfunction
• Plasma phospholipid
fatty acid patterns
and the metabolic
syndrome
• Hypertension and
adiposity in 10- to
14-year-old boys and
girls
• Administration of
tirofiban in diabetics
undergoing primary PCI
Reviews Research Articles Patient Leaflets Drug Trends News